BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33197324)

  • 1. Crosstalk between adipocytes and M2 macrophages compensates for osteopenic phenotype in the
    Li L; Qiu X; Zhang N; Sun Y; Wang Y; Wang L
    Exp Biol Med (Maywood); 2021 Mar; 246(5):572-583. PubMed ID: 33197324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lrp5 and Lrp6 exert overlapping functions in osteoblasts during postnatal bone acquisition.
    Riddle RC; Diegel CR; Leslie JM; Van Koevering KK; Faugere MC; Clemens TL; Williams BO
    PLoS One; 2013; 8(5):e63323. PubMed ID: 23675479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor.
    Kato M; Patel MS; Levasseur R; Lobov I; Chang BH; Glass DA; Hartmann C; Li L; Hwang TH; Brayton CF; Lang RA; Karsenty G; Chan L
    J Cell Biol; 2002 Apr; 157(2):303-14. PubMed ID: 11956231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
    Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
    J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TM9SF4 is a novel regulator in lineage commitment of bone marrow mesenchymal stem cells to either osteoblasts or adipocytes.
    Yu L; Xie M; Zhang F; Wan C; Yao X
    Stem Cell Res Ther; 2021 Nov; 12(1):573. PubMed ID: 34774100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.
    Haÿ E; Laplantine E; Geoffroy V; Frain M; Kohler T; Müller R; Marie PJ
    Mol Cell Biol; 2009 Feb; 29(4):953-64. PubMed ID: 19075000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism.
    Kang KS; Hong JM; Horan DJ; Lim KE; Bullock WA; Bruzzaniti A; Hann S; Warman ML; Robling AG
    Bone; 2019 Mar; 120():166-175. PubMed ID: 30409757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygous deletion of LRP5 gene in mice alters profile of immune cells and modulates differentiation of osteoblasts.
    Li L; Wang Y; Zhang N; Zhang Y; Lin J; Qiu X; Gui Y; Wang F; Li D; Wang L
    Biosci Trends; 2018 Jul; 12(3):266-274. PubMed ID: 29899194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix remodeling associated 7 promotes differentiation of bone marrow mesenchymal stem cells toward osteoblasts.
    Zhou Z; Shen Y; Yin J; Xi F; Xu R; Lin D; Saijilafu ; Chen J; Wang Y
    J Cell Physiol; 2019 Aug; 234(10):18053-18064. PubMed ID: 30843215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Anti-Osteoanabolic Function of Sclerostin Is Blunted in Mice Carrying a High Bone Mass Mutation of Lrp5.
    Yorgan TA; Peters S; Jeschke A; Benisch P; Jakob F; Amling M; Schinke T
    J Bone Miner Res; 2015 Jul; 30(7):1175-83. PubMed ID: 25640331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoblastic Wnts differentially regulate bone remodeling and the maintenance of bone marrow mesenchymal stem cells.
    Wan Y; Lu C; Cao J; Zhou R; Yao Y; Yu J; Zhang L; Zhao H; Li H; Zhao J; Zhu X; He L; Liu Y; Yao Z; Yang X; Guo X
    Bone; 2013 Jul; 55(1):258-67. PubMed ID: 23334081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.
    Sawakami K; Robling AG; Ai M; Pitner ND; Liu D; Warden SJ; Li J; Maye P; Rowe DW; Duncan RL; Warman ML; Turner CH
    J Biol Chem; 2006 Aug; 281(33):23698-711. PubMed ID: 16790443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lrp5/β-Catenin Signaling Controls Lung Macrophage Differentiation and Inhibits Resolution of Fibrosis.
    Sennello JA; Misharin AV; Flozak AS; Berdnikovs S; Cheresh P; Varga J; Kamp DW; Budinger GR; Gottardi CJ; Lam AP
    Am J Respir Cell Mol Biol; 2017 Feb; 56(2):191-201. PubMed ID: 27668462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-deletion of Lrp5 and Lrp6 in the skeleton severely diminishes bone gain from sclerostin antibody administration.
    Lim KE; Bullock WA; Horan DJ; Williams BO; Warman ML; Robling AG
    Bone; 2021 Feb; 143():115708. PubMed ID: 33164872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase-deficient mice exhibit bone loss owing to defects in osteoblasts and increased osteoclastogenesis by inflammatory microenvironment.
    Saeed H; Abdallah BM; Ditzel N; Catala-Lehnen P; Qiu W; Amling M; Kassem M
    J Bone Miner Res; 2011 Jul; 26(7):1494-505. PubMed ID: 21308778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor I-C reciprocally regulates adipocyte and osteoblast differentiation
    Zhou J; Wang S; Qi Q; Yang X; Zhu E; Yuan H; Li X; Liu Y; Li X; Wang B
    FASEB J; 2017 May; 31(5):1939-1952. PubMed ID: 28122918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA LINC00707 promotes osteogenic differentiation of hBMSCs through the Wnt/β-catenin pathway activated by LINC00707/miR-145/LRP5 axis.
    Cai WL; Zeng W; Liu HH; Zhu BY; Liu JL; Liu Y
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):18-28. PubMed ID: 31957814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor receptor superfamily member 19 (TNFRSF19) regulates differentiation fate of human mesenchymal (stromal) stem cells through canonical Wnt signaling and C/EBP.
    Qiu W; Hu Y; Andersen TE; Jafari A; Li N; Chen W; Kassem M
    J Biol Chem; 2010 May; 285(19):14438-49. PubMed ID: 20223822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel therapeutic approach with Caviunin-based isoflavonoid that en routes bone marrow cells to bone formation via BMP2/Wnt-β-catenin signaling.
    Kushwaha P; Khedgikar V; Gautam J; Dixit P; Chillara R; Verma A; Thakur R; Mishra DP; Singh D; Maurya R; Chattopadhyay N; Mishra PR; Trivedi R
    Cell Death Dis; 2014 Sep; 5(9):e1422. PubMed ID: 25232676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal hematopoiesis and lack of β-catenin activation in osteoblasts of patients and mice harboring Lrp5 gain-of-function mutations.
    Galán-Díez M; Isa A; Ponzetti M; Nielsen MF; Kassem M; Kousteni S
    Biochim Biophys Acta; 2016 Mar; 1863(3):490-498. PubMed ID: 26681532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.